Impact of gender: Rivaroxaban for patients with atrial fibrillation in the XANTUS real‐world prospective study

BACKGROUND: The XANTUS study (NCT01606995) demonstrated low rates of stroke and major bleeding in patients with atrial fibrillation (AF) receiving rivaroxaban in clinical practice for the prevention of thromboembolic events (N = 6784). HYPOTHESIS: Because previous real‐world studies have not reporte...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cardiol
Autors principals: Camm, A. John, Amarenco, Pierre, Haas, Sylvia, Bach, Miriam, Kirchhof, Paulus, Kuhls, Silvia, Lambelet, Marc, Turpie, Alexander G.G.
Format: Artigo
Idioma:Inglês
Publicat: Wiley Periodicals, Inc. 2020
Matèries:
Clinical Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724214/
https://ncbi.nlm.nih.gov/pubmed/32896928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23452
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars